Abstract CT101: Final Results of the First-in-human Study of the Porcupine (PORCN) Inhibitor Zamaporvint (RXC004) in Patients with Advanced Solid Tumors

Cancer Research(2024)

引用 0|浏览29
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要